Inventor
YACOBY-ZEEVI ORON
IL23 patents
⚠️ This page may combine multiple inventors who share the name “YACOBY-ZEEVI ORON”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
NEURODERM LTD
13 patentsUS7863336B2Jan 4, 2011
Continuous administration of dopa decarboxylase inhibitors and compositions for same
NEURODERM LTD27 citations96
US9993451B2Jun 12, 2018
Continuous administration of dopa decarboxylase inhibitors and compositions for same
NEURODERM LTD9 citations92
US9040590B2May 26, 2015
Continuous administration of dopa decarboxylase inhibitors and compositions for same
NEURODERM LTD13 citations92
US9040589B2May 26, 2015
Continuous administration of dopa decarboxylase inhibitors and compositions for same
NEURODERM LTD11 citations92
US9040578B2May 26, 2015
Continuous administration of L-dopa, dopa decarboxylase inhibitors, catechol-O-methyl transferase inhibitors and compositions for same
NEURODERM LTD15 citations92
US10813902B2Oct 27, 2020
DOPA decarboxylase inhibitor compositions
NEURODERM LTD5 citations84
US10624839B2Apr 21, 2020
Dopa decarboxylase inhibitor compositions
NEURODERM LTD6 citations84
US10258585B2Apr 16, 2019
DOPA decarboxylase inhibitor compositions
NEURODERM LTD8 citations84
US10022320B2Jul 17, 2018
Dopa decarboxylase inhibitor compositions
NEURODERM LTD8 citations84
US9381249B2Jul 5, 2016
Compositions comprising apomorphine and organic acids and uses thereof
NEURODERM LTD11 citations84
US9040577B2May 26, 2015
Continuous administration of L-dopa, dopa decarboxylase inhibitors, catechol-O-methyl transferase inhibitors and compositions for same
NEURODERM LTD12 citations84
US10525134B2Jan 7, 2020
Compositions comprising apomorphine and organic acids and uses thereof
NEURODERM LTD2 citations73
US9999674B2Jun 19, 2018
Compositions comprising apomorphine and organic acids and uses thereof
NEURODERM LTD1 citations63
INSIGHT STRATEGY & MARKETING
4 patentsUS6153187ANov 28, 2000
Use of glycosaminoglycans degrading enzymes for management of airway associated diseases
INSIGHT STRATEGY & MARKETING67 citations96
US6423312B1Jul 23, 2002
Compositions including glycosaminoglycans degrading enzymes and use of same against surface protected bacteria
INSIGHT STRATEGY & MARKETING15 citations92
US6475763B1Nov 5, 2002
Genetically modified cells and methods for expressing recombinant heparanase and methods of purifying same
INSIGHT STRATEGY & MARKETING30 citations89
US6348344B1Feb 19, 2002
Genetically modified cells and methods for expressing recombinant heparanase and methods of purifying same
INSIGHT STRATEGY & MARKETING32 citations88
YACOBY-ZEEVI ORON
4 patentsUS8193243B2Jun 5, 2012
Continuous administration of dopa decarboxylase inhibitors and compositions for same
YACOBY-ZEEVI ORON27 citations95
US9101663B2Aug 11, 2015
Continuous administration of dopa decarboxylase inhibitors and compositions for same
YACOBY-ZEEVI ORON12 citations92
US9421267B2Aug 23, 2016
Continuous administration of L-dopa, dopa decarboxylase inhibitors, catechol-O-methyl transferase inhibitors and compositions for same
YACOBY-ZEEVI ORON11 citations83
US9415108B2Aug 16, 2016
Compositions for transdermal delivery of active agents
YACOBY-ZEEVI ORON9 citations78